Palantir Has a Hand in NIH’s Most Ambitious Health Initiative
By Julia Métraux,
Mother Jones [cites CGS' Katie Hasson]
| 07. 07. 2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes, and to give all of us access to the personalized information we need to keep ourselves and our families healthier,” Obama said with confidence. “We can do this.” He was met with applause.
That announcement introduced the National Institutes of Health’s “All of US” initiative, designed to organize and provide to researchers the health data of up to a million Americans who opted in to donate their blood, general electronic health records, and more. People’s names are replaced with a code before researchers access their data, and NIH asserts that only a few people have access to the list of codes that correspond with names. As of late June, data from nearly 750,000 participants is available to researchers who are studying such diseases like Alzheimer’s disease and diabetes, as well as overall health patterns like sleep.
Since then...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...